Here's why the ARB Corporation share price is plunging 10% today

The market's responding poorly to the company's latest update.

| More on:
Man with his hand on his face looking at a falling share price chart on a tablet.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The ARB share price is plummeting on Wednesday, slipping 10.8% to trade at $33.75 
  • Its tumble follows the release of an update on the company's performance for the first 9 months of financial year 2022 
  • While the company's revenue and order book – as well as its full year guidance – appear to be strong, it has reported higher expenses and notable macro challenges 

The ARB Corporation Limited (ASX: ARB) share price is tumbling on the release of a trading update.

The S&P/ASX 200 Index (ASX: XJO) company outlined its performance for the financial year to date as of 31 March this morning to the apparent disappointment of the market.

At the time of writing, the ARB share price is $33.75, 10.82% lower than its previous close.

Let's take a look at today's news from the 4X4 accessories manufacturer and distributor.

What's weighing on ARB's stock today?

The ARB share price is in the red after the company updated the market on its performance for the financial year so far. And while its revenue appears to be strong, it's battling numerous challenges.

ARB is struggling against commodity prices and shortfalls, a global shortage of new vehicles, global logistics and pricing, a labour and skills shortage, and exchange rate volatility.

Despite such trials, the company is expecting to report approximately $700 million of revenue for financial year 2022. That's nearly 12% more than it brought in last financial year.

Though, its expenses are also forecast to increase. It's expecting to report expenditure of $57 million this financial year – up from $33.1 million in financial year 2021.

That's been boosted by costs associated with its factories, as well as upgrades to its retail stores and manufacturing equipment.

Back to more positive news, ARB's sales revenue has increased 18% over the 9 months ended 31 March compared to the same period of 2021.

It reached $525 million over that time frame, driven by a 28.4% increase in revenue from ARB's exports market.

The ARB share price might also be suffering on news its Australian new vehicle sales have remained lower than pre-pandemic levels.

Additionally, sales of Toyota Landcruiser wagons – previously one of the company's most popular vehicles ­– fell considerably. ARB states the drop was due to the changeover from the model's 200 series to the 300 series.

Still, the company states that its order book remains high, it's increased its inventory levels to protect against extended lead times, and impacts from new vehicle models haven't flowed through yet.

ARB also noted it's working on emerging partnerships with major customers and the development of new products.

ARB share price snapshot

The ARB share price has been struggling in 2022.

Today's slump included, it has fallen 38% since the start of the year. It's also 10% lower than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ARB Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

businessman handing $100 note to another in supermarket aisle representing woolworths share price
Consumer Staples & Discretionary Shares

How much could $5,000 invested in Coles shares be worth in a year?

Bell Potter sees big returns on the cards for owners of this stock.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Consumer Staples & Discretionary Shares

What are brokers saying about A2 Milk shares?

Is it time to snap up this stock or should you keep your infant formula powder dry?

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Consumer Staples & Discretionary Shares

Should you buy the dip on Woolworths shares?

Is this a good time to look at the supermarket business?

Read more »

Woman in dress sitting in chair looking depressed
Consumer Staples & Discretionary Shares

Cettire share price plunges 6% after major investor pulls the plug

A 'red flag' triggered this investment company to sell out completely.

Read more »

A young woman's hands are shown close up with many blingy gold rings on her fingers and two large gold chains around her neck with dollar signs on them.
Consumer Staples & Discretionary Shares

ASX experts: Lovisa share price has 28% upside

ASX brokers are still rating Lovisa as a compelling buy today.

Read more »

Two colleagues at work looking at a tablet and smiling at a rising share price.
Consumer Staples & Discretionary Shares

Buy this top ASX 200 stock for an 18% gain and 4% dividend yield

Bell Potter has resumed coverage on this stock and is feeling very positive.

Read more »

footwear asx share price on watch represented by look holding shoe and looking intently
Consumer Staples & Discretionary Shares

Does this ASX 300 retail stock really have a 7.6% dividend yield right now?

Is a 7.67% dividend yield too good to be true?

Read more »

A person eats a meat pie on the beach... what's more Australian than that?
Consumer Staples & Discretionary Shares

Which ASX shares could be next on the menu for Ozempic?

This broker believes the market for weight-loss drugs could grow tenfold. What could it consume on its way up?

Read more »